openPR Logo
Press release

Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to 2022 - Dominated by Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy Products

02-15-2019 03:47 PM CET | Health & Medicine

Press release from: ReportsnReports

Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 .

Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America holds largest share of this market. Asia-Pacific region is expected to witness highest CAGR during forecast period of 2017 to 2022.

The global biopsy devices market is projected to reach USD 2.42 billion by 2022 from USD 1.74 billion in 2017, at a CAGR of 6.8% during forecast period. Significant increase in number of people who have cancer, growing number minimally invasive biopsies, and government initiatives in various countries & global health organizations are major factors responsible for growth of biopsy devices market.

Competitive Landscape
1 Introduction
2 Market Share Analysis
3 Competitive Leadership Mapping
4 Visionary Leaders
5 Innovators
6 Emerging Companies
7 Dynamic Differentiators
8 Competitive Benchmarking
9 Strength of Product Portfolio (25 Players)
10 Business Strategyexcellence (25 Players)

Discount on Biopsy Devices Market Now at https://www.reportsnreports.com/contacts/discount.aspx?name=1159148 .

Biopsy devices market ecosystem comprises of following players, namely, C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), and Medtronic plc (Ireland).

Global biopsy devices market segmented into needle-based biopsy instruments, procedure trays, localization wires, and products such as forceps, markers, probes, punches, curettes, and sutures. The needle-based biopsy instruments segment is expected to register highest CAGR during forecast period owing to increasing preference for minimally invasive surgeries and higher preference for needle-based biopsies over open surgical biopsies.

More Information on “Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022” research report can be requested at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1159148 .

The report analyzes the global biopsy devices market by product, guidance technique, application, end user, and region. Based on product, global market is segmented into needle-based biopsy instruments, procedure trays, localization wires, and products. In 2016, needle-based biopsy instruments segment accounted for largest share of global market mainly due to increasing preference for minimally invasive surgeries and higher preference for needle-based biopsies over open surgical biopsies.
Geographically,

The growth of this segment can be attributed to the rising prevalence of cancer, large population in countries such as China and India, improving healthcare infrastructure, increasing healthcare spending and government initiatives, and rising focus of key market players in the region are driving the growth of market in Asia-Pacific.

Same Report is Available Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1169594 .

ReportsnReports is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Number: + 1 888 391 5441
Email Id - sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to 2022 - Dominated by Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy Products here

News-ID: 1592861 • Views:

More Releases from ReportsnReports

Upcoming Conference on Next - Gen Digital Pathology |21st-22nd March 2024 | London
Upcoming Conference on Next - Gen Digital Pathology |21st-22nd March 2024 | Lond …
Integration of artificial intelligence (AI) and Machine learning algorithms into pathology workflows, heralding a new era of efficiency and accuracy at analysing pathology images, managing quality data & aiding pathologists in rapid and precise diagnoses. We at MarketsandMarkets are extremely thrilled to announce our "MarketsandMarkets 2nd Annual Next-Gen Digital Pathology Conference" scheduled to be held on 21st - 22nd March 2024. The conference promises an immersive exploration into the future of
(EU Edition) High Potent Medicines Conference | 22nd - 24th May 2024 |9th Annual MarketsandMarkets
(EU Edition) High Potent Medicines Conference | 22nd - 24th May 2024 |9th Annual …
Welcome to the MarketsandMarkets 9th High Potent Medicines Conference- the premier gathering for pioneers and experts in the realm of Highly Potent Active Pharmaceutical Ingredients (HPAPIs). This transformative event converges industry leaders and regulatory professionals on a singular platform dedicated to exploring cutting-edge developments in the development, manufacturing, and safe handling of highly potent compounds. Engage with real-world experiences and case studies from companies at the forefront of successful HPAPI programs.
Upcoming Conference on Advanced Pre-Filled Syringes and Parenteral Solutions|22nd - 23rd May 2024 |Milan, Italy
Upcoming Conference on Advanced Pre-Filled Syringes and Parenteral Solutions|22n …
Pioneering Precision: Unveiling the Future of Injectable Therapies In the ever- evolving landscape of healthcare, the significance of pre-filled syringes and parenteral delivery systems cannot be overstated and thus our focus today is on the vital realm of injectable therapies. Injectable therapies are at the nexus of precision medicine, playing a pivotal role in patient care and treatment outcomes. Welcome to MarketsandMarkets NextGen Inject: Conference on Advanced Pre-Filled Syringes and Parenteral Solutions
Global Stoma Care Market Key Players are Coloplast de Argentina S.A. (Argentina), Coloplast Pty. Ltd. (Australia), Coloplast do Brasil Ltda. (Brazil), Lilial S.A.S. (France), Coloplast Turkey AS (Turkey), Coloplast Corp. (USA), Coloplast Korea Limited (Ko
Global Stoma Care Market Key Players are Coloplast de Argentina S.A. (Argentina) …
The global Stoma Care Market is projected to reach USD 3.2 billion by 2026, at a CAGR of 4.3%. The increasing target patient population, growing prevalence of inflammatory bowel diseases, rising geriatric population, growing awareness, technological advancements, and the favorable reimbursement system in developed countries are the major factors driving the growth of this market. However, discomfort and other issues associated with the use of ostomy bags and the growing

All 5 Releases


More Releases for Biopsy

Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Needle Biopsy Industry 2018, Market Structure - By Type Fine-Needle Aspiration B …
Needle Biopsy Market information: by type (fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, image-guided biopsy) by utility (disposable, reusable), by applications (tumor, infection, Inflammation, others) - Global Forecast till 2023. Considering all these factors the market for Needle Biopsy is expected to reach $ 677 million by the end of 2023, this market is projected to be growing at a CAGR of ~ 5.2 % during 2017-2023. KEY PLAYERS OF NEEDLE
Global Breast Biopsy Devices Market In Japan: By Product - Biopsy Needles, Biops …
Researchmoz added Most up-to-date research on "Global Breast Biopsy Devices Market In Japan: By Product - Biopsy Needles, Biopsy Tables, Guidance Systems & Localization Wires" to its huge collection of research reports. The global Breast Biopsy Devices market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Japan plays an
Liquid Biopsy Market Liquid Biopsy Technology Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Liquid Biopsy: A Non-Invasive, Game-Changer Diagnostic Tool 2. Mechanism of Action: Major Components of Liquid Biopsy 2.1 Circulating Tumor Cells 2.1.1 Parameters Guiding Circulating Cell Tumors 2.2 Circulating Tumor Nucleic Acids (ctNA) 2.2.1 Cell-Free Tumor DNA 2.2.2 Other Circulatory Tumor Nucleic Acid: microRNA, mRNA & Long Non-Coding